Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first821 to 840 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| CTSL cathepsin L | 1514 HGNC:2537 | 1 | 201 | 0 | 0 | 3,990 | 8,838 |
| CD22 CD22 molecule | 933 HGNC:1643 | 1 | 153 | 13 | 116 | 3,092 | 8,823 |
| GNAI1 G protein subunit alpha i1 | 2770 HGNC:4384 | 1 | 43 | 0 | 0 | 5,645 | 8,816 |
| ARNT aryl hydrocarbon receptor nuclear translocator | 405 HGNC:700 | 1 | 39 | 0 | 0 | 4,552 | 8,812 |
| CTSS cathepsin S | 1520 HGNC:2545 | 1 | 102 | 1 | 1 | 4,858 | 8,800 |
| G6PC1 glucose-6-phosphatase catalytic subunit 1 | 2538 HGNC:4056 | 1 | 63 | 0 | 0 | 2,574 | 8,800 |
| NAMPT nicotinamide phosphoribosyltransferase | 10135 HGNC:30092 | 1 | 185 | 3 | 4 | 3,358 | 8,796 |
| TCF4 transcription factor 4 | 6925 HGNC:11634 | 1 | 49 | 0 | 0 | 5,331 | 8,773 |
| MAP3K7 mitogen-activated protein kinase kinase kinase 7 | 6885 HGNC:6859 | 1 | 29 | 0 | 0 | 4,695 | 8,752 |
| CANX calnexin | 821 HGNC:1473 | 1 | 125 | 0 | 0 | 5,253 | 8,739 |
| AIF1 allograft inflammatory factor 1 | 199 HGNC:352 | 1 | 80 | 0 | 0 | 6,355 | 8,722 |
| KRT5 keratin 5 | 3852 HGNC:6442 | 1 | 51 | 0 | 0 | 4,227 | 8,719 |
| CLDN1 claudin 1 | 9076 HGNC:2032 | 1 | 261 | 0 | 0 | 3,217 | 8,712 |
| PRDM9 PR/SET domain 9 | 56979 HGNC:13994 | 1 | 17 | 0 | 0 | 5,637 | 8,690 |
| APEX1 apurinic/apyrimidinic endodeoxyribonuclease 1 | 328 HGNC:587 | 1 | 128 | 1 | 1 | 4,298 | 8,674 |
| FADD Fas associated via death domain | 8772 HGNC:3573 | 1 | 81 | 0 | 0 | 3,976 | 8,672 |
| HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 | 3117 HGNC:4942 | 1 | 65 | 0 | 0 | 4,420 | 8,655 |
| FBXW7 F-box and WD repeat domain containing 7 | 55294 HGNC:16712 | 1 | 86 | 0 | 0 | 3,780 | 8,651 |
| H1-1 H1.1 linker histone, cluster member | 3024 HGNC:4715 | 1 | 28 | 0 | 0 | 1,557 | 8,643 |
| APAF1 apoptotic peptidase activating factor 1 | 317 HGNC:576 | 1 | 32 | 0 | 0 | 3,251 | 8,636 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=42
{
"data": {
"total": 193990,
"results": [
{
"id": "1514",
"title": "CTSL: cathepsin L",
"summary": "NCBI Gene 1514. 1 protein, 201 patents, 0 drugs, 0 trials, 3,990 NIH grants and 8,838 papers.",
"record": "/library/genes/1514",
"gene_id": 1514,
"symbol": "CTSL",
"name": "cathepsin L",
"hgnc_id": "HGNC:2537",
"counts": {
"proteins": 1,
"patents": 201,
"drugs": 0,
"trials": 0,
"grants": 3990,
"papers": 8838
}
},
{
"id": "933",
"title": "CD22: CD22 molecule",
"summary": "NCBI Gene 933. 1 protein, 153 patents, 13 drugs, 116 trials, 3,092 NIH grants and 8,823 papers.",
"record": "/library/genes/933",
"gene_id": 933,
"symbol": "CD22",
"name": "CD22 molecule",
"hgnc_id": "HGNC:1643",
"counts": {
"proteins": 1,
"patents": 153,
"drugs": 13,
"trials": 116,
"grants": 3092,
"papers": 8823
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=43",
"request_id": "rhcq_u123Teic96q"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant